Investor Relations

Stock Information.


View Detailed Stock Information

Latest News.

VolitionRx Limited to Present at Jefferies Global Healthcare Conference

Read Press Release

VolitionRx Limited Announces First Quarter 2024 Financial Results and Business Update

Read Press Release

VolitionRx Limited Schedules First Quarter 2024 Earnings Conference Call and Business Update

Read Press Release

Nu.Q® Vet Cancer Test launched in-clinic in U.S. and Europe through Antech

Read Press Release

VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business Update

Read Press Release

VolitionRx Limited Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call and Business Update

Read Press Release

Volition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer Test in Japan

Read Press Release

Volition appoints Dr Andrew Retter as Chief Medical Officer

Read Press Release

Volition to Share Nu.Q® NETs Strategy Update at Upcoming Webinar

Read Press Release

Latest Financial Results.

Q1 2024

Quarter Ended Mar 31, 2024

Latest Event.

2024 Annual Meeting of Stockholders

Company Overview.

Volition is a multi-national epigenetics company focused on advancing the science of epigenetics. Volition is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring.

Through its subsidiaries, Volition is developing and commercializing simple, easy to use, cost-effective blood tests to help diagnose and monitor a range of diseases, including some cancers and diseases associated with NETosis, such as sepsis. Early diagnosis and monitoring have the potential not only to prolong the life of patients, but also improve their quality of life.

Volition's research and development activities are centered in Belgium, with an innovation laboratory and office in the U.S. and additional offices in London and Singapore.

IR Contacts.

Corporate Office

VolitionRx Ltd
1489 West Warm Springs Road
Suite 110
Henderson, NV 89014
Phone: +1-646-650-1351
info@volition.com

Investor Relations

VolitionRx
Phone: +1-646-650-1351
investorrelations@volition.com

Edison Advisors
Soo Romanoff
Phone: +1-773-573-9779
sromanoff@edisongroup.com

Transfer Agent

VStock Transfer, LLC
18 Lafayette Place
Woodmere, NY 11598
Phone: +1-212-828-8436
F: +1-646-536-3179
info@vstocktransfer.com
https://www.vstocktransfer.com